Esposito Pamela (CIK 0001744425)

Latest company ownership

Shares held
5,000
Last filed at
Jun 3, 2025
Confidence Score
17.1
2025Q4
Confidence Score History
2024Q3 2025Q4
REPL - Replimune Group, Inc.
Role: Chief Business Officer
Shares held
300
Last filed at
Sep 13, 2023
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q3 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Dec 17, 2025 Dec 17, 2025 Kymera Therapeutics, Inc. Director Sell 5.0 -27,563 -100.00% ✓ $2.3M
Jun 3, 2025 Jun 3, 2025 Kymera Therapeutics, Inc. Director Sell 10.0 -5,000 -100.00% ✓ $245.2K
Dec 2, 2024 Dec 2, 2024 Kymera Therapeutics, Inc. Director Sell 10.0 -2,500 -100.00% ✓ $122.5K
Sep 17, 2024 Sep 17, 2024 Kymera Therapeutics, Inc. Director Sell 7.5 -13,500 -100.00% ✓ $651.8K
Sep 11, 2023 Sep 13, 2023 Replimune Group, Inc. Chief Business Officer Sell 45.0 -5,658 -1.06% ✓ $113.2K
Aug 22, 2023 Aug 24, 2023 Replimune Group, Inc. Chief Business Officer Sell 30.0 -18,600 -6.59% ✓ $372.2K
Aug 11, 2023 Aug 15, 2023 Replimune Group, Inc. Chief Business Officer Sell 51.3 -1,400 -0.53% ✓ $28K
Jul 10, 2023 Jul 11, 2023 Replimune Group, Inc. Chief Business Officer Sell 30.0 -20,000 -7.06% ✓ $431.5K
May 16, 2023 May 18, 2023 Replimune Group, Inc. Chief Business Officer Sell 42.5 -5,966 -2.21% ✗ $107.7K
Dec 9, 2022 Dec 13, 2022 Replimune Group, Inc. Chief Business Officer Sell 30.0 -15,000 -6.14% ✓ $375.5K
May 16, 2022 May 18, 2022 Replimune Group, Inc. Chief Business Officer Sell 42.5 -3,507 -1.51% ✗ $51.2K
Aug 4, 2021 Aug 6, 2021 Replimune Group, Inc. Chief Business Officer Sell 27.5 -30,000 -6.66% ✓ $1.1M
Jul 20, 2021 Jul 22, 2021 Replimune Group, Inc. Chief Business Officer Sell 35.0 -17,400 -3.98% ✓ $576.6K
Jul 15, 2021 Jul 19, 2021 Replimune Group, Inc. Chief Business Officer Sell 41.3 -4,600 -2.14% ✓ $153.5K
Jan 14, 2021 Jul 19, 2021 Replimune Group, Inc. Chief Business Officer Sell 27.5 -55,000 -7.20% ✓ $2.4M
Jan 14, 2021 Jan 19, 2021 Replimune Group, Inc. Chief Business Officer Sell 27.5 -55,000 -7.20% ✓ $2.4M
Oct 14, 2020 Oct 16, 2020 Replimune Group, Inc. Chief Business Officer Sell 22.5 -16,000 -12.43% ✓ $526.4K
Aug 31, 2020 Sep 1, 2020 Replimune Group, Inc. Chief Business Officer Sell 37.5 -5,000 -4.25% ✓ $135.3K